PH23901A - Treatment of diabetes using fluoxetine - Google Patents

Treatment of diabetes using fluoxetine

Info

Publication number
PH23901A
PH23901A PH36859A PH36859A PH23901A PH 23901 A PH23901 A PH 23901A PH 36859 A PH36859 A PH 36859A PH 36859 A PH36859 A PH 36859A PH 23901 A PH23901 A PH 23901A
Authority
PH
Philippines
Prior art keywords
fluoxetine
diabetes
treatment
mammals
found
Prior art date
Application number
PH36859A
Other languages
English (en)
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH23901A publication Critical patent/PH23901A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
PH36859A 1987-05-04 1988-04-29 Treatment of diabetes using fluoxetine PH23901A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (1)

Publication Number Publication Date
PH23901A true PH23901A (en) 1989-12-18

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36859A PH23901A (en) 1987-05-04 1988-04-29 Treatment of diabetes using fluoxetine

Country Status (11)

Country Link
EP (1) EP0294028B1 (de)
JP (1) JP2721507B2 (de)
KR (1) KR880013555A (de)
AT (1) ATE93721T1 (de)
AU (1) AU596296B2 (de)
DE (1) DE3883606T2 (de)
DK (1) DK238588A (de)
ES (1) ES2058272T3 (de)
HK (1) HK19595A (de)
PH (1) PH23901A (de)
ZA (1) ZA883115B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449562A3 (en) * 1990-03-29 1992-03-18 Eli Lilly And Company Use of r-fluoxetine as selective serotonin ic-receptor ligands
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
MXPA05011557A (es) 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
CA2630624C (en) * 2005-11-22 2013-08-06 Orexigen Therapeutics, Inc. Compositions and methods for increasing insulin sensitivity
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20180066272A (ko) 2006-11-09 2018-06-18 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
KR20190042766A (ko) 2006-11-09 2019-04-24 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
MX344303B (es) 2010-01-11 2016-12-13 Orexigen Therapeutics Inc Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
IL300868A (en) 2012-06-06 2023-04-01 Orexigen Therapeutics Inc Methods for treating overweight and obesity
US20150190352A1 (en) 2012-07-31 2015-07-09 Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret Anonim Sirketi Use of fluoxetine in animals
US20150174083A1 (en) 2012-07-31 2015-06-25 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Use of fluoxetine for increasing meat and milk production
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
CA1267092A (en) * 1985-02-25 1990-03-27 Martin D. Hynes Analgesic composition containing codeine

Also Published As

Publication number Publication date
AU596296B2 (en) 1990-04-26
JP2721507B2 (ja) 1998-03-04
KR880013555A (ko) 1988-12-21
JPS63284126A (ja) 1988-11-21
AU1553388A (en) 1988-11-10
DE3883606D1 (de) 1993-10-07
EP0294028A2 (de) 1988-12-07
HK19595A (en) 1995-02-17
ATE93721T1 (de) 1993-09-15
DE3883606T2 (de) 1994-01-20
DK238588A (da) 1988-11-05
EP0294028B1 (de) 1993-09-01
ES2058272T3 (es) 1994-11-01
DK238588D0 (da) 1988-05-03
EP0294028A3 (en) 1990-05-02
ZA883115B (en) 1990-01-31

Similar Documents

Publication Publication Date Title
PH23901A (en) Treatment of diabetes using fluoxetine
EP0185980A3 (en) Oxygen enriching apparatus
IE840493L (en) Biosynthetically produced human nerve growth factor.
EP0189680A3 (en) Stabilizing power source apparatus
IE882529L (en) Platinum Coordination Compound
PT84294A (en) Novel treatment
GB8625912D0 (en) Thermochemical treatment
GB2211845B (en) Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles
EP0310893A3 (en) Vulcanizable fluororubber composition
PH25095A (en) Beta-alkylmelatonins
ZA857721B (en) Process for treatment of rheumatic diseases
GB2198451B (en) Briquette treatment process
GB2158112B (en) Treatment process for utilization of rubber wood
GB2206821B (en) Improvements relating to surface treatment
GB8622419D0 (en) Treatment/therapy for diabetes sufferes
ZA884799B (en) Novel treatment
EP0238765A3 (en) 2,2-diphenoxy-n,n-dimethylaminoethane for improving cerebral oxygenation
GB8615059D0 (en) Oxygen using
ZA883322B (en) Yeast treatment process
AU7384187A (en) Coal treatment process
GB8702771D0 (en) Treatment for burn
GB8709875D0 (en) Treatment
GB8712238D0 (en) Treatment
GB8708042D0 (en) Treatment